1. Home
  2. MLTX vs AVDX Comparison

MLTX vs AVDX Comparison

Compare MLTX & AVDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • AVDX
  • Stock Information
  • Founded
  • MLTX 2021
  • AVDX 2000
  • Country
  • MLTX Switzerland
  • AVDX United States
  • Employees
  • MLTX N/A
  • AVDX N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • AVDX EDP Services
  • Sector
  • MLTX Health Care
  • AVDX Technology
  • Exchange
  • MLTX Nasdaq
  • AVDX Nasdaq
  • Market Cap
  • MLTX 2.4B
  • AVDX 2.0B
  • IPO Year
  • MLTX N/A
  • AVDX 2021
  • Fundamental
  • Price
  • MLTX $41.16
  • AVDX $9.77
  • Analyst Decision
  • MLTX Strong Buy
  • AVDX Hold
  • Analyst Count
  • MLTX 8
  • AVDX 15
  • Target Price
  • MLTX $77.71
  • AVDX $10.04
  • AVG Volume (30 Days)
  • MLTX 293.0K
  • AVDX 8.5M
  • Earning Date
  • MLTX 05-12-2025
  • AVDX 05-07-2025
  • Dividend Yield
  • MLTX N/A
  • AVDX N/A
  • EPS Growth
  • MLTX N/A
  • AVDX N/A
  • EPS
  • MLTX N/A
  • AVDX 0.01
  • Revenue
  • MLTX N/A
  • AVDX $441,284,000.00
  • Revenue This Year
  • MLTX $103.42
  • AVDX $5.73
  • Revenue Next Year
  • MLTX N/A
  • AVDX $10.25
  • P/E Ratio
  • MLTX N/A
  • AVDX $1,092.72
  • Revenue Growth
  • MLTX N/A
  • AVDX 10.46
  • 52 Week Low
  • MLTX $31.42
  • AVDX $6.61
  • 52 Week High
  • MLTX $58.26
  • AVDX $12.93
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 58.30
  • AVDX 72.60
  • Support Level
  • MLTX $37.80
  • AVDX $8.12
  • Resistance Level
  • MLTX $40.71
  • AVDX $9.81
  • Average True Range (ATR)
  • MLTX 1.81
  • AVDX 0.03
  • MACD
  • MLTX 0.14
  • AVDX -0.04
  • Stochastic Oscillator
  • MLTX 99.42
  • AVDX 55.56

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About AVDX AvidXchange Holdings Inc.

AvidXchange Holdings Inc is a provider of AP automation software and payment solutions for middle-market businesses and their suppliers. It generates the majority of its sales from Payment revenue followed by Software revenue and Services revenue. The company generates revenue in the United States.

Share on Social Networks: